Co And Helixnano Enter MoU For Vaccine Development - SEC Filing
Aug 4 (Reuters) - Medicus Pharma Ltd MDCX.O: MEDICUS PHARMA LTD - CO AND HELIXNANO ENTER MOU FOR VACCINE DEVELOPMENT - SEC FILING MEDICUS PHARMA LTD - CO AND HELIXNANO TO COLLABORATE ON MRNA VACCINE-LOADED MNAS PRODUCTION THROUGH JV - SEC FILING Further company coverage: MDCX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medicus Pharma
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Medicus Pharma Submits Optimized Teverelix® Registrational Protocol To FDA To Create Partner Ready Program In Advanced Prostate Cancer